René Gagnon

Effect of Alipogene Tiparvovec (AAV1-LPL^S447X) on Postprandial Chylomicron Metabolism in Lipoprotein Lipase-Deficient Patients

André C. Carpentier, Frédérique Frisch, Sébastien M. Labbé et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 163 citations · Full text

Life Sciences, Nutritional Sciences, Pharmacology +17

Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI

Christiane Auray‐Blais, Patrick Bhérer, René Gagnon et al. · Molecular Genetics and Metabolism · 2010 · 108 citations

Life Sciences, Biochemistry, Pathology +4

How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?

Christiane Auray‐Blais, Aimé Ntwari, Joe T.R. Clarke et al. · Clinica Chimica Acta · 2010 · 100 citations

Pharmacy, Biochemistry, Molecular Medicine +10

Urinary Globotriaosylsphingosine-Related Biomarkers for Fabry Disease Targeted by Metabolomics

Christiane Auray‐Blais, Michel Boutin, René Gagnon et al. · Analytical Chemistry · 2012 · 95 citations

Life Sciences, Biochemistry, Molecular Medicine +17

Optimization of the Potency and Pharmacokinetic Properties of a Macrocyclic Ghrelin Receptor Agonist (Part I): Development of Ulimorelin (TZP-101) from Hit to Clinic

Hamid R. Hoveyda, Éric Marsault, René Gagnon et al. · Journal of Medicinal Chemistry · 2011 · 82 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17